Internal Medicine NewsFDA advisers set high bar for new opioidsJanuary 21, 2020PainAddiction MedicineNeurology
Internal Medicine NewsFDA committee rejects oxycodegol, new opioid designed for less abuseJanuary 14, 2020PainMental HealthNeurology
Internal Medicine NewsFDA okays ubrogepant for acute migraine treatmentDecember 23, 2019PainNeurology
Internal Medicine NewsWell-tolerated topical capsaicin formulation reduces knee OA painDecember 18, 2019RheumatologyPain
Internal Medicine NewsIn addiction, abusive partners can wreak havocDecember 9, 2019Opioid Resource CenterAddiction MedicineMental HealthPain
Internal Medicine NewsAddiction specialists: Cannabis policies should go up in smokeDecember 9, 2019Addiction MedicineNeurologyMental HealthPain
Internal Medicine NewsSurvey: Cancer-related pain, opioid use up since 2018November 25, 2019OncologyOpioid Resource CenterPainHematology
Internal Medicine NewsOA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factorsNovember 24, 2019RheumatologyPain
Internal Medicine NewsElagolix is effective second-tier treatment for endometriosis-associated dysmenorrheaNovember 22, 2019Women's HealthPainEndocrinology
Internal Medicine NewsCannabis frequently is used for endometriosis painNovember 21, 2019Women's HealthPain
Internal Medicine NewsChildren may develop prolonged headache after concussionNovember 18, 2019NeurologyPain
Internal Medicine NewsFDA announces approval of fifth adalimumab biosimilar, AbriladaNovember 18, 2019GastroenterologyDermatologyRheumatologyPain
Internal Medicine NewsSupport for medical marijuana transcends political affiliationNovember 15, 2019OncologyPainAddiction Medicine
Internal Medicine NewsOpioid reduction works after minimally invasive gynecologic surgeryNovember 14, 2019Opioid Resource CenterWomen's HealthPainPreventive CareAddiction Medicine
Internal Medicine NewsCBD: What physicians need to know about itOctober 28, 2019PainMental HealthNeurologyMusculoskeletal DisordersAddiction Medicine